Acquired Kyrle's disease at the site of healed herpes zoster
Keywords:
Kyrle's disease is a rare variant of primary perforating dermatosis .We reported a case of Kyrle's disease involving the site of healed herpes zoster. The clinical picture shows follicular and interfollicular hyperkeratotic horn-like plugs at the site ofAbstract
Kyrle's disease is a rare variant of primary perforating dermatosis .We reported a case of Kyrle's disease involving the site of healed herpes zoster. The clinical picture shows follicular and interfollicular hyperkeratotic horn-like plugs at the site of the resolved herpes zoster. It is thought to be an isotopic response that describes the occurrence of a new skin disorder at the site of another lesion that has already healed and is unrelated.References
Moss HV. Kyrle's disease. Cutis 1979; 23: 463-6.
Huntley AC. The cutaneous manifestations of diabetes mellitus. J Am Acad Dermatol 1982; 7:427-4.
Petrozzi JW, Warthan TL. Kyrle's disease. Treatment with topically applied tretinoin. Arch Dermatol 1974; 110: 762-5.
Tessler HH, Apple DJ, Goldberg MF. Ocular findings in kindred with Kyrle’s disease. Arch Opthalmol 1973; 90: 278-80.
Cunningham SR, Walsh H, Path M et al. Kyrle’s disease. J Am Acad Dermatol 1987; 16: 117-23.
Wolf R, Brenner S, Ruocco V et al. Isotopic response. Int J Dermatol 1995; 34: 341-8.
Bang SW, Kim YK, Whang KU. Acquired reactive perforating collagenosis: unilateral umbilicated papules along the lesions of herpes zoster. J Am Acad Dermatol 1997; 26: 778-9.
Hye Nam Lee, Dong Won Lee, Jun Young Lee et al. Two cases of reactive perforating collagenosis arising at the site of healed herpes zoster. Int J Dermatol 2001; 40: 191-209.
Livia Zanardo, Wilhelm Stolz, Michael Landthaler et al. Reactive perforating collagenosis after disseminated zoster. Dermatology 2001; 203: 273-5.
Patterson JW. The perforating disorders. J Am Acad Dermatol 1984; 10: 561-81.
Sehgal VN, Jain S, Thappa DM et al. Perforating dermatoses: A review and report of four cases. J Dermatol 1993; 20: 329-40.
Kuokkanen K, Niemi KM, Reunala T. Parakeratotic horns in a patient with myeloma. J Cutan Pathol 1987; 14: 54-8.
Hinrichs W, Breuckmann F, Altmeyer P et al. Acquired perforating dermatosis: a report on 4 cases associated with scabies infection. J Am Acad Dermatol 2004; 51: 665-7.
Woodrow SL, Rytina ERC, Norris PG. Kyrle’s en plaque. Clin Exp Dermatol 1999; 24: 48-9.
Alyahya GA, Heegaard S, Prause JU. Ocular changes in a case of Kyrle’s disease. 20-year follow-up. Acta Ophthalmol 2000; 78: 585-9.
Golusin Z, Poljacki M, Matovic L et al. Kyrle’s disease. Med Pregl 2002; 55: 47-50.
Detmar M, Ruszczak Z, Imcke E et al. Kyrle disease in juvenile diabetes mellitus and chronic renal failure. Z Hautkr 1990; 65: 53-61.
Harman M, Aytekin S, Akdeniz S et al. Kyrle’s disease in diabetes mellitus and chronic renal failure. J Eur Acad Dermatol Venereol 1998; 11: 87-8.
Tomecki KJ, Battaglini JW, Maize JC. Kyrle’s disease and type II hyperlipoproteinemia. Arch Dermatol 1980; 116: 227-8.
Bazex A, Dupre A, Parant M. Kyrle’s palmoplantar disease. Role of arsenic in its etiology. Arch Belg Dermatol Syphiligr 1961; 17: 41-6.
Yanagihara M, Fujita T, Shirasaki A et al. The pathogenesis of the transepithelial elimination of the collagen bundles in acquired reactive perforating collagenosis. J Cutan Pathol 1996; 23:398-403.
Morgan MB, Truitt CA, Taira J et al. Fibronectin and the extracellular matrix in the perforating disorders of the skin. Am J Dermatopathol 1998; 20: 147-54.
Kasiakou SK, Peppas G, Kapaskelis AM et al. Regression of the skin lesions of Kyrle’s disease with clindamycin: implications for an infectious component in the etiology of the disease. J Infect 2005; 50: 412-6.
Khalifa M, Slim I, Kaabia N et al. Regression of skin lesions of Kyrle’s disease with metronidazole in a diabetic patient. J Infect 2007; 55: e139-40.
